For: | Bertol FS, Araujo B, Jorge BB, Rinaldi N, De Carli LA, Tovo CV. Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. World J Gastrointest Surg 2020; 12(6): 269-276 [PMID: 32774765 DOI: 10.4240/wjgs.v12.i6.269] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i6/269.htm |
Number | Citing Articles |
1 |
Liwan Fu, Yuquan Wang, Yue-Qing Hu. Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1015046
|
2 |
Mary Barbara, Ayse L. Mindikoglu. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. Metabolism Open 2021; 11: 100105 doi: 10.1016/j.metop.2021.100105
|
3 |
Xiaohui Liu, Hong Shen, Mingfeng Chen, Jun Shao. Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.760985
|
4 |
Yesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda. Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis. Annals of Hepatology 2022; 27(6): 100706 doi: 10.1016/j.aohep.2022.100706
|
5 |
Ke Liu, Ying Chen, Jiaxin Chen, Weiwei Chen, Xiaohui Sun, Yingying Mao, Ding Ye. Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51609-3
|
6 |
Magdalena Tyczyńska, Gabriela Hunek, Martyna Szczasny, Adam Brachet, Jacek Januszewski, Alicja Forma, Piero Portincasa, Jolanta Flieger, Jacek Baj. Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(9): 4916 doi: 10.3390/ijms25094916
|
7 |
Huan-Huan Yang, Guo-Chong Chen, De-Ming Li, Lei Lan, Li-Hua Chen, Jia-Ying Xu, Li-Qiang Qin. Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89991-x
|